Filing Details
- Accession Number:
- 0001645627-17-000089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-05 15:22:58
- Reporting Period:
- 2017-06-30
- Filing Date:
- 2017-07-05
- Accepted Time:
- 2017-07-05 15:22:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,467,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,469,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,471,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,473,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,475,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,477,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,479,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 4,000 | $0.03 | 21,483,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,485,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,487,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,489,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,491,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,493,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,495,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,497,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,499,349 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,501,349 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |